Presentation TVT 2012 Perspectives from the "Extreme Risk" Cohort of the US CoreValve Study Presenter: Neal Kleiman June 04, 2012 REGISTER for free or LOG IN to view this content Aortic Valve Presentation TVT 2012 Up Next Presentation TVT 2012 EU Insights on Withholding TAVR in Futile Patients Presenter: Neil Moat June 04, 2012 More slides + Presentation TVT 2012 The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions Presenter: Saibal Kar June 05, 2012 Presentation TVT 2012 A Primer on Risk Scores: Use and Abuse(2) Presenter: Vinod Thourani June 05, 2012 We Recommend
Presentation TVT 2012 EU Insights on Withholding TAVR in Futile Patients Presenter: Neil Moat June 04, 2012
Presentation TVT 2012 The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions Presenter: Saibal Kar June 05, 2012
Presentation TVT 2012 A Primer on Risk Scores: Use and Abuse(2) Presenter: Vinod Thourani June 05, 2012